A cohort study investigating aspirin use and survival in men with prostate cancer

Abstract LB-15: Frequency of aspirin use and prostate cancer mortality among prostate cancer cases in the control arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

(2014) Sarah E. Daugherty et al.   CANCER RESEARCH

Diabetes and cancer I: risk, survival, and implications for screening

(2012) Adedayo A. Onitilo et al.   CANCER CAUSES & CONTROL

Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort

(2012) P. K. Dhillon et al.   Cancer Prevention Research

Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy

(2012) Kevin S. Choe et al.   JOURNAL OF CLINICAL ONCOLOGY

Daily Aspirin Use and Cancer Mortality in a Large US Cohort

(2012) E. J. Jacobs et al.   JNCI-Journal of the National Cancer Institute

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

(2012) Neil E Fleshner et al.   LANCET

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Aspirin and the risk of prostate cancer mortality

(2012) Carlo La Vecchia et al.   Nature Reviews Clinical Oncology

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

(2012) Helene Hartvedt Grytli et al.   PROSTATE

Smoking and Prostate Cancer Survival and Recurrence

(2011) Stacey A. Kenfield   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE

(2010) Matthew S. Katz et al.   BJU INTERNATIONAL

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET